High response rate and improvement of long-term survival with combined treatment modalities in patients with poor-risk primary thyroid diffuse large B-cell lymphoma: an International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi s (Q53158556)

From Wikidata

Jump to navigation Jump to search

scientific article published on 21 February 2011

Language	Label	Description	Also known as
English	High response rate and improvement of long-term survival with combined treatment modalities in patients with poor-risk primary thyroid diffuse large B-cell lymphoma: an International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi s	scientific article published on 21 February 2011

Statements

scholarly article

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/21338283

High response rate and improvement of long-term survival with combined treatment modalities in patients with poor-risk primary thyroid diffuse large B-cell lymphoma: an International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi s (English)

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/21338283

B-cell lymphoma

1 reference

based on heuristic

inferred from title

diffuse large B-cell lymphoma

1 reference

based on heuristic

inferred from title

Gianluca Gaidano

2

object named as

Gianluca Gaidano

1 reference

Europe PubMed Central

11 May 2018

19

object named as

Franco Cavalli

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/21338283

Massimo Federico

object named as

Massimo Federico

10

1 reference

ORCID Public Data File 2021

author name string

Michael Mian

1

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/21338283

Annarita Conconi

3

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/21338283

Richard Tsang

4

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/21338283

Mary K Gospodarowicz

5

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/21338283

Alessandro Rambaldi

6

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/21338283

Andrea Rossi

7

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/21338283

Elena Oldani

8

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/21338283

Massimo Federico

9

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/21338283

Stefano Luminari

11

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/21338283

Monica Bellei

12

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/21338283

Enrico M Pogliani

13

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/21338283

Fausto Rossini

14

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/21338283

Maria Elena Cabrera

15

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/21338283

Maurizio Martelli

16

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/21338283

Armando Lopez-Guillermo

17

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/21338283

Mario Busetto

18

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/21338283

Emanuele Zucca

20

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/21338283

Sergio Cortelazzo

21

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/21338283

publication date

21 February 2011

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/21338283

Leukemia & Lymphoma

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/21338283

52

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/21338283

5

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/21338283

823-832

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/21338283

Anaplastic thyroid cancer and primary thyroid lymphoma: a review of these rare thyroid malignancies

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.555888

21 January 2018

Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.555888

21 January 2018

Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.555888

21 January 2018

Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.555888

21 January 2018

An evidence-based approach to the treatment of thyroid lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.555888

21 January 2018

Thyroid lymphoma. The case for combined modality therapy

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.555888

21 January 2018

Outcome analysis for stage IE and IIE thyroid lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.555888

21 January 2018

Clinicopathologic correlations of stage IE/IIE primary thyroid diffuse large B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.555888

21 January 2018

A reassessment of primary thyroid lymphoma: high-grade MALT-type lymphoma as a distinct subtype of diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.555888

21 January 2018

Primary thyroid lymphoma: a retrospective analysis of prognostic factors and treatment outcome for localized intermediate and high grade lymphoma.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.555888

21 January 2018

Treatment and survival of patients with thyroid lymphoma: a population-based study with clinical and pathologic reviews.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.555888

21 January 2018

Brief chemotherapy and involved-region irradiation for limited-stage diffuse large-cell lymphoma: an 18-year experience from the British Columbia Cancer Agency.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.555888

21 January 2018

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.555888

21 January 2018

Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.555888

21 January 2018

ACOD, a modified CHOP regimen for elderly patients with aggressive non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.555888

21 January 2018

The place of third-generation regimens in the treatment of adult aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.555888

21 January 2018

Revised response criteria for malignant lymphoma.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.555888

21 January 2018

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.555888

21 January 2018

T-cell lymphoma in Hashimoto's thyroiditis.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.555888

21 January 2018

Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.555888

21 January 2018

Clinical characteristics of primary thyroid lymphoma in Koreans.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.555888

21 January 2018

Primary thyroid lymphoma is a heterogeneous disease.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.555888

21 January 2018

Primary malignant lymphoma of the thyroid-a tumour of mucosa-associated lymphoid tissue: review of seventy-six cases

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.555888

21 January 2018

Clonal relationship between Hashimoto thyroiditis and thyroid lymphoma.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.555888

21 January 2018

Clonal B cell populations in a minority of patients with Hashimoto's thyroiditis

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.555888

21 January 2018

Hashimoto's thyroiditis manifesting monoclonal lymphocytic infiltration.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.555888

21 January 2018

Treatment results and prognostic factors in primary thyroid lymphoma patients: a rare cancer network study

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.555888

21 January 2018

Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern Cooperative Oncology Group study 1484.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.555888

21 January 2018

ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.555888

21 January 2018

Diffuse aggressive lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.555888

21 January 2018

High incidence of Pneumocystis jirovecii pneumonia in patients receiving biweekly rituximab and cyclophosphamide, adriamycin, vincristine, and prednisone

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.555888

21 January 2018

Clinico-biological characterization and outcome of primary nodal and extranodal diffuse large B-cell lymphoma in the rituximab era.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.555888

21 January 2018

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.555888

21 January 2018

Non-hodgkin's lymphoma of the thyroid gland: Prognostic factors and treatment outcome

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.555888

21 January 2018

Identifiers

10.3109/10428194.2011.555888

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/21338283

1 reference

Europe PubMed Central

11 May 2018

http://europepmc.org/abstract/MED/21338283

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53158556&oldid=1583079284"